Dr Saadvik Raghuram Y
Director of Medical Oncology & Hemato-oncology
Qualifications
MBBS, MD(Radiation Oncology),
DM(Medical Oncology), MRCP(UK), ECMO (European Certified medical oncologist ) , PDCR(Clinical Research)
Department of Medical Oncology
Experience
12+ years
Book Appointment Now
Dr. Saadvik Raghuram Y is one of the best medical oncologists and hemato-oncologists in Hyderabad, with over 12+ years of experience in advanced cancer care. He is currently serving as the Director of Medical Oncology & Hemato-Oncology at CARE Hospitals, Banjara Hills, Hyderabad.
Recognized as a top cancer specialist in Hyderabad, Dr. Saadvik is known for his patient-centric and holistic approach to cancer treatment. He specializes in managing a wide spectrum of cancers, including breast cancer, stomach cancer, gynecological cancers, colorectal cancer, liver cancer, esophageal cancer, prostate cancer, kidney cancer, bladder cancer, oral cancer, brain tumors, and lung cancer.
His clinical expertise includes chemotherapy, immunotherapy, targeted therapy, hormone therapy, cancer screening, palliative care, and cancer genetic counseling. He is also actively involved in clinical trials and evidence-based oncology practices, ensuring patients receive the most advanced and personalized treatment options.
Dr. Saadvik completed his MBBS from JSS Medical College, Mysore, followed by a Master’s in Radiation Oncology from Sri Aurobindo Institute of Medical Sciences, Indore. He further pursued super-specialization in Medical Oncology from Amrita Institute of Medical Sciences, Kochi, strengthening his expertise in comprehensive cancer care.
Known for his precision in diagnosis and compassionate care, Dr. Saadvik actively participates in oncology research and academic initiatives. He has multiple publications to his credit and regularly engages in workshops and conferences to stay at the forefront of cancer treatment advancements.
MBBS, MD(Radiation Oncology),
DM(AIMS),ECMO (European Certified medical oncologist ) ,
PDCR
- Breast cancer
- Stomach cancer
- Colorectal cancer
- Liver cancer
- Esophageal cancer
- Prostate cancer
- Kidney cancer
- Bladder cancer
- Oral cancers
- Brain tumours
- Lung cancer
- Sarcomas
- Lymphoma
- Multiple Myeloma
- Lumbar puncture and Intrathecal chemotherapy
- Bone marrow aspiration and biopsy
- Targeted therapy
- Immunotherapy
- Hormonal therapy
- Precision medicine
- Palliative and supportive care for end stage cancers
- Cancer genetic counselling
- Familial and hereditary cancer syndromes management
- Sickle Cell Disease
- Iron Deficiency
- Bleeding & Clotting Disorders
- Septicemia
- Von Willebrand Disease
- Polycythemia
- Myelodysplastic Syndrome (MSD)
- Immune Thrombocytopenic Purpura
- Stroke
- Acute Lymphoblastic Leukemia
- Member, European Society of Medical Oncology (ESMO) – ID No: 412228
- American Society of Clinical Oncology (ASCO)
- American Society of Hematology (ASH)
- Indian Society of Medical and Paediatric Oncology (ISMPO)- ID No: 1432 Member, Chapter
- FIRST PRIZE IN QUIZ: Oncology 2018: International conference on multidisciplinary management of common cancers, October 2018
- FIRST PRIZE IN QUIZ: Amala Oncology Breast Cancer Conference, March 2020.
- SECOND PRIZE FOR BEST ORAL PAPER: Indian Association of supportive care in cancer (IASCC) under the aegis of Multinational association of supportive care in cancer (MASCC) September 2020. Prevalence of distress among cancer patients and factors associated with it: A prospective observational study.
- THIRD PRIZE FOR BEST POSTER PRESENTATION AROICON MP-CG chapter 2016. Primary squamous cell carcinoma of breast: A case report
- ESMO PRECEPTORSHIP COURSE on Prostate cancer advancements- TRAVEL GRANT by European society of medical oncology, SINGAPORE
- ESMO PRECEPTORSHIP COURSE on Bladder and Kidney cancer- TRAVEL GRANT by European Society of medical oncology, SINGAPORE
- Thromboembolic events in advanced non-small cell lung cancer. Annals of oncology (2019)30 (suppl_2): ii38-1168.10.1093/annoc/mdz063.
- Rising thyroid cancer incidence in Kerala: Is it real or over diagnosis? J Clin Oncol 37(15_suppl):e17589.May 2019.
- The value of low, fixed, single dose rasburicase in the prevention and treatment of tumor lysis syndrome. J Clin Oncol 37, 2019(suppl;e 18558)
- The association of the uterine motion with bladder volume during radiotherapy in gynaecological malignancies. Journal of Cancer Metastasis and Treatment. 2016;2(4):139.
- Incidence of second primary malignant neoplasm in Malwa region of central India – Journal of Cancer Research and Therapeutics,14(5),999.
- Pemetrexed-Associated Hyperpigemented Skin Rash. American journal of therapeutics. U.S. National Library of Medicine; 2020.Available from: https://www.ncbi.nlm.nih.gov/pubmed/32039988.
- Orbital metastasis as the presenting feature of carcinoma breast. Indian Journal of cancer education and research. 4. 67-70. 10.21088/ijcer.2321.9815.4216.5.
Meet Dr. Saadvik Raghuram:
Best Oncologist in Hyderabad
Request a Consultation
fill out the form below and we’ll get backshortly
